Biocryst Pharmaceuticals (BCRX) Change in Inventory (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Change in Inventory came in at $4.8 million in Q1 2026, up 457.13% YoY from $870000.0 in Q1 2025, and up 841.17% on a QoQ basis from $515000.0 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Change in Inventory (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 13 years of Change in Inventory data on file, last reported at $4.8 million in Q1 2026.
- Quarterly Change in Inventory rose 457.13% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (up 47.25% YoY) and the FY2025 annual result came in at $1.6 million, down 60.64% from the prior year.
- Change in Inventory grew to $4.8 million in Q1 2026, from $515000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $7.2 million in Q2 2022 to a low of -$1.4 million in Q2 2025.
- A 5-year average of $1.4 million and a median of $1.2 million in 2022 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory sank 178.19% — and 2024, when it soared 1031.3%.
- Tracing BCRX's Change in Inventory over 5 years: stood at $1.2 million in 2022, then tumbled by 178.19% to -$907000.0 in 2023, then surged by 338.48% to $2.2 million in 2024, then tumbled by 76.19% to $515000.0 in 2025, then surged by 841.17% to $4.8 million in 2026.
- The last three Change in Inventory figures came in at $4.8 million (Q1 2026), $515000.0 (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.35 Mn |
| Jun 30, 2026 | 4.35 Mn |
| Mar 31, 2026 | 4.85 Mn |
| Mar 31, 2026 | 4.85 Mn |
| Dec 31, 2025 | 515,000.00 |
| Dec 31, 2025 | 515,000.00 |
| Sep 30, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Mar 31, 2025 | 870,000.00 |
| Mar 31, 2025 | 870,000.00 |
| Dec 31, 2024 | 2.16 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | -739,000.00 |
| Jun 30, 2024 | -739,000.00 |
| Mar 31, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.22 Mn |